ARTICLE | Management Tracks
New CEOs at Alterome, Valo and Imbria
Plus: Updates from Harbour BioMed, Ottimo and NeOnc
April 10, 2025 10:44 PM UTC
Targeted oncology company Alterome Therapeutics Inc. named Jung Choi CEO. She had been an entrepreneur-in-residence since the $5.4 billion acquisition by Pfizer Inc. (NYSE:PFE) of Global Blood Therapeutics Inc., where she was chief business and strategy officer. Alterome has raised more than $231 million in private funding, including a $132 million series B in April 2024.
Helsinki-based oncolytic virus company Valo Therapeutics Ltd. named Marcella Origgi CEO. Based in Italy, she arrives from Johnson & Johnson Innovation, where she played a role in sourcing opportunities for investment and partnering...